Back to results
CompletedPhase 1

A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

NCT00001444

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Cancer Institute (NCI)

Bethesda, Maryland, United States

View on ClinicalTrials.gov
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms — TrialFind